| S9667 |
Inobrodib (CCS-1477)
|
Inobrodib (CCS1477; CBP-IN-1; CBP/p300-IN-4)is a potent and selective inhibitor of p300/CBP bromodomain. CCS1477 works by inhibiting the expression and function of the androgen receptor (AR), as well as inhibiting c-Myc.
|
-
Nat Genet, 2025, 57(10):2468-2481
-
Nat Commun, 2025, 16(1):4133
-
PLoS Pathog, 2025, 21(9):e1013073
|
|
| S8740 |
A-485
|
A-485 is a potent, selective and drug-like p300/CBP catalytic inhibitor with an IC50 of 0.06 μM for p300 HAT. It is selective over BET bromodomain proteins and >150 non-epigenetic targets.
|
-
Nat Genet, 2025, 57(10):2468-2481
-
Cancer Discov, 2025, 15(2):382-400
-
Nat Cell Biol, 2025, 10.1038/s41556-025-01658-1
|
|
| S8968 |
PRI-724 (Foscenvivint)
|
Foscenvivint (PRI-724) is a potent and specific inhibitor that disrupts the interaction of β-catenin and CBP.
|
-
Cancer Discov, 2025, 10.1158/2159-8290.CD-25-0629
-
Cell Death Dis, 2025, 16(1):466
-
Biomed Pharmacother, 2025, 188:118225
|
|
| S2662 |
ICG-001
|
ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to CREB-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coactivator p300. ICG-001 induces apoptosis.
|
-
Cancer Discov, 2025, 10.1158/2159-8290.CD-25-0629
-
Adv Sci (Weinh), 2025, 12(40):e05702
-
Cell Rep Med, 2025, 6(2):101927
|
|
| S1848 |
Curcumin
|
Curcumin (Diferuloylmethane, Natural Yellow 3, Turmeric yellow) is the principal curcuminoid of the popular Indian spice turmeric, which is a member of the ginger family (Zingiberaceae). It is an inhibitor of p300 histone acetylatransferase(IC50~25 μM)and Histone deacetylase (HDAC); activates Nrf2 pathway and supresses the activation of NF-κB. Curcumin induces mitophagy, autophagy, apoptosis, and cell cycle arrest with antitumor activity. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death. Curcumin exhibits anti-infective properties against various human pathogens like the influenza virus, hepatitis C virus, HIV and so on.
|
-
J Biol Chem, 2025, 301(7):110305
-
Mol Pain, 2025, 21:17448069251323668
-
BMC Immunol, 2025, 26(1):67
|
|
| S7256 |
SGC-CBP30
|
SGC-CBP30 is a potent CREBBP/EP300 inhibitor with IC50 of 21 nM and 38 nM in cell-free assays, respectively. Exhibits 40-fold and 250-fold selectivity for CBP over the first BRD of BRD4 (BRD4(1)) and BRD4(2) respectively.
|
-
Mol Cell, 2025, 85(8):1525-1542.e10
-
Cell Death Dis, 2025, 16(1):193
-
Cell Rep, 2025, 44(4):115523
|
|
| S7582 |
Anacardic Acid
|
Anacardic Acid (6-pentadecylsalicylic Acid) is a potent inhibitor of p300 and p300/CBP-associated factor histone acetyltranferases, which also has antibacterial activity, antimicrobial activity,
prostaglandin synthase inhibition, and tyrosinase and lipoxygenase inhibition.
|
-
Sci Adv, 2025, 11(9):eadq2881
-
J Transl Med, 2024, 22(1):995
-
Int J Mol Sci, 2024, 25(17)9600
|
|
| S8190 |
CPI-637
|
CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor with IC50 values of 0.03 μM and 0.051μM for CBP and EP300 respectively in TR-FRET assay. It is highly selective against other bromodomains, displaying substantial biochemical activity only against BRD9.
|
-
Mol Cell Proteomics, 2023, 22(3):100504
-
Acta Pharmacol Sin, 2019, 10.1038/s41401-019-0237-5
|
|
| E1348 |
E7386
|
E-7386 is a selective inhibitor which inhibits interaction between CBP/beta-catenin with IC50 value of 0.0484 μM in HEK293 cells.
|
-
Adv Sci (Weinh), 2024, 11(35):e2308417
-
Cell Rep, 2024, 43(8):114532
|
|
| S6758 |
I-CBP112
|
I-CBP112 is a potent and selective CBP/p300 inhibitor with dissociation constant (KD) of 151 ± 6 nM and 167 ± 8 nM for CBP and p300, respectively.
|
-
Hepatology, 2021, 10.1002/hep.32245
|
|